Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Cancer Research|May 4, 2005
Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignanciesHideki Kasuya, Darshini K Kuruppu, James M Donahue, et al.
Annals of Surgical Oncology|March 23, 2021
Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric CancerDerek J Erstad, Mariela Blum, Jeannelyn S Estrella, et al.
Surgery|June 1, 2021
Benchmarks for nodal yield and ratio for node-positive gastric cancerDerek J Erstad, Mariela Blum, Jeannelyn S Estrella, et al.
Clinics in Colon and Rectal Surgery|March 6, 2019
Contemporary Opportunity for Prehabilitation as Part of an Enhanced Recovery after Surgery Pathway in Colorectal SurgeryZhi Ven Fong, David C Chang, Keith D Lillemoe, et al.
Cancer Gene Therapy|February 1, 2023
Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastasesDarshini Kuruppu, Deepak Bhere, Christian T Farrar, et al.
BMC Cancer|July 20, 2014
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liverAlexandra Naba, Karl R Clauser, Charles A Whittaker, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 17, 2013
Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusionKoichi Hayano, Gaurav S Desai, Avinash R Kambadakone, et al.
Cancer Investigation|February 25, 2012
Angiogenesis inhibition using an oncolytic herpes simplex virus expressing endostatin in a murine lung cancer modelJonathan M Goodwin, Anthony D Schmitt, Christopher M McGinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Cancer Research|April 3, 2008
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cellsBryan C Fuchs, Tsutomu Fujii, Jon D Dorfman, et al.
Pageof 20